Latest News - International Approval

Monday, September 22, 2014 | International Approval

Bayer Receives Approval for Eylea for the Treatment of Myopic Choroidal Neovascularization in Japan

Bayer HealthCare has received approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Eylea (aflibercept solution for injection) for the treatment of myopic choroidal neovasculariz…

Read the full story